Legal Representation
Attorney
Stephen P. McNamara
USPTO Deadlines
Next Renewal Deadline
1750 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-23)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
40 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 23, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Apr 23, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Mar 21, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Mar 20, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Mar 17, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Mar 17, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Feb 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 23, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Feb 23, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
Feb 23, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
Feb 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 23, 2024 | IUAF | S | USE AMENDMENT FILED |
Oct 11, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Aug 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 18, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
Aug 18, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
Aug 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jan 6, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jan 6, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
Jan 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 23, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jun 28, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 28, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jun 8, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
May 20, 2022 | ALIE | A | ASSIGNED TO LIE |
May 19, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 19, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
May 19, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
May 19, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
May 19, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
May 17, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 16, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
May 16, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Dec 9, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Dec 9, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
Dec 9, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
Dec 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 19, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Immunochromatographic test cartridges for clinical testing the presence of antibodies to gluten; medical devices, namely, immunochromatographic test cartridges, for clinical testing for anti-tissue transglutaminase IgA antibodies; celiac disease diagnosis and screening testing kits comprised of disinfectant alcohol wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, blood collection micropipette to obtain blood sample from lancet site, container of dilution buffer to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood sample; gluten sensitivity and intolerance testing kits comprised of disinfectant wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, micropipette to obtain blood sample from lancet site, container of diluent to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood
First Use Anywhere:
Nov 13, 2023
First Use in Commerce:
Nov 13, 2023
Additional Information
Pseudo Mark
CELIA CARE
Classification
International Classes
005